Research Use Notice TB-500 + BPC-157 is provided strictly for laboratory research and development purposes
Even through manufacturer self-pay programs, most eligible Medicare-age patients not on the Bridge are still looking at $149 to $449 a month, depending on the drug and dose, per CNNs reporting on the launch
By helping nerve cells maintain their cytoskeletal framework, TB-500 may help prevent the permanent nerve death that often follows chronic injury [6]
Our team will evaluate your body goals, health, and lifestyle to craft a customized weight loss and body contouring plan
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is the first of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1